Various routes of administration of 99mTc-labeled synthetic lactoferrin antimicrobial peptide hLF 1-11 enables monitoring and effective killing of multidrug-resistant Staphylococcus aureus infections in mice

Peptides

Volumn 29, Issue 7, 2008, Pages 1109-1117

  Brouwer, Carlo P J M ^a   Welling, Mick M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

99mTc labeling; Antibacterial therapy; Lactoferrin peptide; MRSA infection; Routes of administration; Scintigraphy

Indexed keywords

LACTOFERRIN; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN HLF 1 11; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG INHIBITION; GALLBLADDER; IMMUNOCOMPETENCE; INTESTINE; ISOTOPE LABELING; KIDNEY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOACTIVITY; SCINTIGRAPHY; STAPHYLOCOCCUS INFECTION;

ALANINE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; QUALITY CONTROL; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TECHNETIUM; TISSUE DISTRIBUTION;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MUS; STAPHYLOCOCCUS AUREUS;

EID: 44649095568     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.03.003     Document Type: Article

References (35)

1. Autelitano D.J., Rajic A., Smith A.I., Berndt M.C., Ilag L.L., and Vadas M. Drug Discov Today 11 (2006) 306-314
2. Brouwer C.P.J.M., Wulferink M., and Welling M.M. The pharmacology of radiolabeled cationic antimicrobial peptides. J Pharma Sci 97 (2008) 1633-1651
3. Dale B.A., Tao R., Kimball J.R., and Jurevic RJ. BMC Oral Health 6 Suppl. 1 (2006) S13
4. Dial E.J., and Lichtenberger L.M. Biochem Cell Biol 80 (2002) 113-117
5. Dial E.J., Romero J.J., Headon D.R., and Lichtenberger L.M. J Pharm Pharmacol 52 (2000) 1541-1546
6. Dijkshoorn L., Brouwer C.P.J.M., Bogaards S.J.P., Nemec A., van den Broek P.J., and Nibbering P.H. Antimicrob Agents Chemother 48 (2004) 4919-4921
7. Edde L., Hipolito R.B., Hwang F.F.Y., Headon D.R., Shalwitz R.A., and Sherman M.P. Am J Physiol Gastr L. 281 (2001) G1140-G1150
8. Hancock R.E.W. Expert Opin Investig Drugs 9 (2000) 1723-1729
9. Ji B., Maeda A., Higuchi M., Inoue K., Akita H., Harashima H., et al. Life Sci 78 (2006) 851-855
10. Klevens R.M., Morrison M.A., Nadle J., Petit S., Gershman K., Ray S., et al., For the Active Bacterial Core Surveillance (ABCs) MRSA Investigators. JAMA 298 (2007) 1763-1771
11. Lowy F.D. N Engl J Med 339 (1998) 520-532
12. Lupetti A., Paulusma-Annema A., Welling M.M., Dogterom-Ballering H., Brouwer C.P.J.M., Senesi S., et al. Antimicrob Agents Chemother 47 (2003) 262-267
13. Lupetti A., Paulusma-Annema A., Welling M.M., Senesi S., Van Dissel J.T., and Nibbering P.H. Antimicrob Agents Chemother 44 (2000) 3257-3263
14. Lupetti A., Welling M.M., Mazzi U., Nibbering P.H., and Pauwels E.K.J. Eur J Nucl Med Mol I 29 (2002) 674-679
15. Lupetti A., Brouwer C.P.J.M., Bogaards S.J.P., Welling M.M., de Heer E., Campa M., et al. J Infect Dis 196 (2007) 1416-1424
16. Madison M.N., Kleshchenko Y.Y., Nde P.N., Simmons K.J., Lima M.F., and Villalta F. Infect Immun 75 (2007) 4780-4791
17. Morishita M., and Peppas N.A. Drug Discov Today 11 (2006) 905-910
18. Mulligan M.E., Murray-Leisure K.A., Ribner B.S., Standiford H.C., John J.F., Korvick J.A., et al. Am J Med 94 (1993) 313-328
19. Nibbering P.H., Ravensbergen E., Welling M.M., van Berkel L.A., van Berkel P.H.C., Pauwels E.K.J., et al. Infect Immun 69 (2001) 1469-1476
20. Nibbering P.H., Welling M.M., Paulusma-Annema A., Brouwer C.P.J.M., Lupetti A., and Pauwels E.K.J. J Nucl Med 45 (2004) 321-326
21. Schneider-Lindner V., Delaney J.A., Dial S., Dascal A., and Suissa S. Emerg Infect Dis 13 (2007) 994-1000
22. Scott M.G., and Hancock R.E.W. Crit Rev Immunol 20 (2000) 407-431
23. Shan T., Wang Y., Wang Y., Liu J., and Xu Z. J Anim Sci 85 (2007) 2140-2146
24. Stallmann H.P., Faber C., Amerongen A.V.N., and Wuisman P.I.J.M. Injury 37 (2006) 34-40
25. Swart P.J., Harmsen M.C., Kuipers M.I., Van Dijk A.A., Van der Strate B.W.A., van Berkel P.H.C., et al. J Pept Sci 5 (1999) 563-576
26. Takakura N., Wakabayashi H., Ishibashi H., Yamauchi K., Teraguchi S., Tamura Y., et al. J Med Microbiol 53 (2004) 495-500
27. Welling M.M., Hiemstra P.S., van den Barselaar M.T., Paulusma-Annema A., Nibbering P.H., Pauwels E.K.J., et al. J Clin Invest 102 (1998) 1583-1590
28. Welling M.M., Lupetti A., Balter H.S., Lanzzeri S., Souto B., Rey A.M., et al. J Nucl Med 42 (2001) 788-794
29. Welling M.M., Mongera S., Lupetti A., Balter H.S., Bonetto V., Mazzi U., et al. Nucl Med Biol 29 (2002) 413-422
30. Welling M.M., Paulusma-Annema A., Balter H.S., Pauwels E.K.J., and Nibbering P.H. Eur J Nucl Med 27 (2000) 292-301
31. Welling M., Feitsma H.I.J., Calame W., and Pauwels E.K.J. Nucl Med Biol 24 (1997) 649-655
32. Wright G.D., and Sutherland A.D. Trends Mol Med 13 (2007) 260-267
33. Wulferink M, Brouwer CP, Sluiter-van Dijk AMC, Blijlevens NNA, Donnelly JP, Velders MP. ASH Annual Meeting Abstracts 2005;106:3241.
34. Yamaguchi H., Abe S., and Takakura N. Biometals 17 (2004) 245-248
35. Zasloff M. Nature 415 (2002) 389-395